TEVA
Teva Pharmaceutical-sp Adr
3 of the 83 super-investors we track hold TEVA, worth a combined $153M per their latest 13F filings. The largest position: Harry Burn at 4.0% of their portfolio. This quarter the cohort logged 0 buys and 1 sell on the name. Conviction score: 24 of 100 (how strongly the cohort backs it) — ranked #565 of 742 stocks. Conviction rising: 1 more super-investor hold it than in 2026Q1.
Why super-investors own TEVA
TEVA is held by 3 super-investors in our cohort, with a combined position value of $153M. The highest-conviction owner is Harry Burn at 4.0% of their portfolio. Cohort ownership has shrunk from 5 to 3 over the last four quarters — net interest is fading. This quarter the cohort registered 1 trimmed.
AI-synthesized from 13F filings. Not investment advice.
Cohort owners over time
2016Q3 → 2026Q2How many of the cohort members held this stock each quarter.
Owners (3) · click any column to sort
| #↑ | Manager | % Port. | History | Value | Shares |
|---|---|---|---|---|---|
| 1 | Harry Burn | 4.0% | 12q | $129M | 3,804,497 |
| 2 | Stanley Druckenmiller | 0.5% | 8q | $21M | 624,999 |
| 3 | Joel Greenblatt | <0.1% | 39q | $2M | 73,304 |
Owners of TEVA also hold
Congress is trading TEVA
Congress tracker →- Greg Gianfortebought$15,001 - $50,000 · 2020-11-13
- Donna Shalalasold$1,001 - $15,000 · 2020-05-07
- David E. Pricesold$1,001 - $15,000 · 2019-06-19
- Patty Murraysold$1,001 - $15,000 · 2017-06-15
- Angus S Kingsold$1,001 - $15,000 · 2016-10-19
- K. Michael Conawaysold$1,001 - $15,000 · 2016-09-12
STOCK Act periodic transaction reports; amounts are disclosed ranges. Who files late →
Recent activity (1)
| Manager | Move | % Port. | Δ Shares | Value | Filed |
|---|---|---|---|---|---|
| Stanley Druckenmiller | TRIM | 0.5% | -74% | $21M | Aug 14, 2026 |
Long US equity 13F-HR filings only. CUSIP 881624209. Not investment advice.